Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-005724

CEO and CFO bought 600 shares at $16.53 ($9,918)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2023-02-17 Purchase +600 $16.53 $9,918 2,736,486 D
Open-market purchases · 600 sh · avg $16.53 · $9,918
Loading xslF345X03/ownership.xml…